UBS AM’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$46.7K Buy
+1,104
New +$40.5K ﹤0.01% 3431

Other funds holding IDNA

UBS AM's IDNA Position: Q3 2026 in Review

UBS AM opened a new position in iShares Genomics Immunology and Healthcare ETF (IDNA) in Q3 2026: 1,104 shares worth $46.7K. The stake represents ﹤0.01% of the portfolio and ranks #3431 among its holdings.

80 funds tracked by Wall St. Rank hold IDNA as of Q3 2026.

  • UBS AM held 1,104 shares of iShares Genomics Immunology and Healthcare ETF worth $46.7K as of Q3 2026.
  • iShares Genomics Immunology and Healthcare ETF was a new UBS AM position in Q3 2026.
  • iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #3431 holding.
  • 80 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2026.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.